Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Cancer

Parker Institute for Cancer Immunotherapy Awards $3m to Early Career Investigators in Ongoing Fight Against Cancer Thanks to Tech Riches

The Parker Institute for Cancer Immunotherapy (PICI) recently announced its 2021 class of early career researcher award recipients, a group […]

Parker Institute for Cancer Immunotherapy Awards $3m to Early Career Investigators in Ongoing Fight Against Cancer Thanks to Tech Riches
3 days ago
Share

Cancer Research as a Care Option in Rural Montana—The State has Come A Long Way

The clinical research as a care option has come a long way in the large, massive, primarily rural State of […]

Cancer Research as a Care Option in Rural Montana—The State has Come A Long Way
5 days ago
Share

University of Kansas Cancer Center Introduces the Next Level App Supporting the Growing Clinical Research as a Care Option Advance

The University of Kansas Cancer Center has developed a new mobile app to match anyone looking for specific cancer trials with […]

University of Kansas Cancer Center Introduces the Next Level App Supporting the Growing Clinical Research as a Care Option Advance
1 week ago
Share

$250m Philanthropic Capital Infusion Launches Break Through Cancer Targeting Cures for Most Intractable Cancers

One of the largest gifts, even in support of cancer research, $250 million thanks to Mr. and Mrs. William H. […]

$250m Philanthropic Capital Infusion Launches Break Through Cancer Targeting Cures for Most Intractable Cancers
1 week ago
Share

Dr. John Boockvar Of Lenox Hill Hospital Talks New Surgical Technique To Treat Glioblastoma| Podcast

We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started […]

2 weeks ago
Share

Genmab’s Epcoritamab Evaluated in Phase 3 Clinical Trial Targeting Relapsed Refractory Diffuse Large B-Cell Lymphoma

Danish biotech venture Genmab in partnership with American multinational pharmaceutical company AbbVie recently launched a Phase 3 clinical trial to […]

Genmab’s Epcoritamab Evaluated in Phase 3 Clinical Trial Targeting Relapsed Refractory Diffuse Large B-Cell Lymphoma
2 weeks ago
Share

Stuttering and the Speak Freely Study, An Interview With Dr. Gerald Maguire of UC Riverside| Podcast

An interview with Dr. Gerald Maguire about the Phase 2 Speak Freely Study, which is a multicenter, randomized, double-blind, placebo-controlled, […]

3 weeks ago
Share

Regeneron’s Libtayo Approved by the FDA as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

The U.S. Food and Drug Administration granted approval of a drug that is the first immunotherapy treatment indicated for patients […]

Regeneron’s Libtayo Approved by the FDA as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
3 weeks ago
Share

“Smart” Natural Killer Cells For Cancer Treatment, A Interview With Sonny Hsiao of Acepodia | Podcast

  We discuss “Smart” Natural Killer Cells for Cancer Treatment, Sonny Hsiao of Acepodia. A clinical trial targeting HER2-expressing solid […]

4 weeks ago
Share

Erasmus MC Spin-off Secures Seeding Funding in Rotterdam to Develop Life-Saving T-cell Therapies for Solid Tumors

An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. […]

Erasmus MC Spin-off Secures Seeding Funding in Rotterdam to Develop Life-Saving T-cell Therapies for Solid Tumors
4 weeks ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.